| HOME >> BIOLOGY >> TECHNOLOGY |
26,682,870 31,295,699
------------ ------------
------------ ------------
SemBioSys Genetics Inc.
Consolidated Statements of Loss, Comprehensive Loss and Deficit
(Unaudited)
-------------------------------------------------------------------------
(expressed in Canadian dollars, except shares)
Three month period ended
March 31, March 31,
2008 2007
$ $
Revenue
Licensing fees 50,110 437,012
Contract research - 105,776
Product sales 159,917 -
------------ ------------
210,027 542,788
Expenses
Research and development 2,794,103 1,743,973
General and administration 1,395,275 1,023,711
Intellectual property costs 342,330 528,249
Business development 159,630 309,474
Sales and marketing 153,160 -
Cost of products sold 271,745 -
Stock-based compensation 179,903 179,050
Amortization 493,834 228,058
Cost recoveries (532,369) (69,107)
'/>"/>
| SOURCE SemBioSys Genetics Inc. Copyright©2008 PR Newswire. All rights reserved |